SIREN : 433924529
LDR MEDICAL is a French company founded 25 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in SAINTE-SAVINE (10300), this company of category ETI shows in 2021 a revenue of 31.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 | 2020 | 2019 | 2018 | 2016 |
|---|---|---|---|---|---|
| Revenue | 31 535 759 € | 35 427 742 € | 48 232 427 € | 105 073 367 € | 46 246 060 € |
| Net income | 6 425 543 € | 9 309 056 € | 4 659 507 € | 22 949 245 € | -38 025 932 € |
| EBITDA | 3 109 993 € | 2 216 077 € | 174 424 € | 35 235 171 € | -29 574 298 € |
| Net margin | 20.4% | 26.3% | 9.7% | 21.8% | -82.2% |
In 2021, LDR MEDICAL achieves revenue of 31.5 M€. Revenue is declining over the period 2016-2021 (CAGR: -7.4%). Significant drop of -11% vs 2020. After deducting consumption (5.6 M€), gross margin stands at 25.9 M€, i.e. a rate of 82%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3.1 M€, representing 9.9% of revenue. Positive scissor effect: EBITDA margin improves by +3.6 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 6.4 M€, i.e. 20.4% of revenue. This profit can be retained or distributed to shareholders.
31 535 759 €
25 936 523 €
3 109 993 €
12 829 478 €
6 425 543 €
9.9%
The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 34.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
43.338%
63.981%
34.57%
2.836
20.2%
In 2021, the debt ratio of LDR MEDICAL (43.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2021, the financial autonomy of LDR MEDICAL (64.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2021, the repayment capacity of LDR MEDICAL (2.84) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 993.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 119.3x. Operating income very largely covers interest expenses: high safety margin.
993.933
119.276
In 2021, the liquidity ratio of LDR MEDICAL (993.93) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2021, the interest coverage of LDR MEDICAL (119.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 107 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 95 days. The company must finance 12 days of gap between collections and payments. Inventory turnover is 40 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 915 days of revenue, i.e. 80.1 M€ to permanently finance. Over 2016-2021, WCR increased by +167%, requiring additional financing.
80 122 588 €
107 j
95 j
40 j
915 j
Based on 57 transactions of similar company sales
(all years),
the value of LDR MEDICAL is estimated at
10 008 422 €
(range 2 682 848€ - 19 510 206€).
With an EBITDA of 3 109 993€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LDR MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of LDR MEDICAL in 2021 is 31.5 M€.
Yes, LDR MEDICAL generated a net profit of 6.4 M€ in 2021.
The headquarters of LDR MEDICAL is located in SAINTE-SAVINE (10300), in the department Aube.
The tax return of LDR MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LDR MEDICAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.